A IMMOUNLOGICAL EPITOPE OF THE HIV STRAIN TYPE O AND THE USES THEREOF

Details for Australian Patent Application No. 2002325467 (hide)

Owner TSINGHUA UNIVERSITY

Inventors DONG, Xiaonan; XIAO, Yi; CHEN, Yinghua

Pub. Number AU-A-2002325467

PCT Number PCT/CN02/00552

PCT Pub. Number WO2004/011490

Priority 02125373.0 29.07.02 CN

Filing date 9 August 2002

Wipo publication date 16 February 2004

International Classifications

C07K 014/155 Peptides having more than 20 amino acids

C12N 005/12 Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

C07K 016/08 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from viruses

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 02125373.0 29.07.02 CN

25 March 2004 Application Open to Public Inspection

  Published as AU-A-2002325467

14 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

18 August 2005 Corrigenda

  Applications OPI - Name Index Under the name TSINGHUA UNIVERSITY, Application No. 2002325467, under INID (71) correct the name to read TSINGHUA UNIVERSITY; BEIJING QINGDA YINGHUA BIO-TECH CO., LTD.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002325468-AN ORIENTATION APPARATUS ADJUSTING THE LOUDSPEAKER'S SOUND EFFECT

2002325466-THE ANTIBODY DIRECTED AGAINST THE HIV STRAIN TYPE O, THE HYBRIDOMA CELL LINE PRODUCING IT AND THE USES THEREOF